Efficacy analysis of combinatorial siRNAs against HIV derived from one double hairpin RNA precursor

Frontiers in Microbiology

Volumn 8, Issue AUG, 2017, Pages

  Liu, Chang ^a   Liang, Zhipin ^a   Kong, Xiaohong ^a  

^a NANKAI UNIVERSITY   (China)

Author keywords

Escaping mutation; Gene therapy; HIV; Long term inhibition; RNAi

Indexed keywords

EID: 85028473461     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2017.01651     Document Type: Article

References (32)

1. Allers, K., Hutter, G., Hofmann, J., Loddenkemper, C., Rieger, K., Thiel, E., et al. (2011). Evidence for the cure of HIV infection by CCR5Delta32/Delta32 stem cell transplantation. Blood 117, 2791–2799. doi: 10.1182/blood-2010-09-309591
2. Berkhout, B., and Das, A. T. (2012). HIV-1 escape from RNAi antivirals: Yet another Houdini action? Mol. Ther. Nucleic Acids. 1, e26. doi: 10.1038/mtna.2012.22
3. Brummelkamp, T. R., Bernards, R., and Agami, R. (2002). A system for stable expression of short interfering RNAs in mammalian cells. Science 296, 550–553. doi: 10.1126/science.1068999
4. Castanotto, D., Li, H., and Rossi, J. J. (2002). Functional siRNA expression from transfected PCR products. RNA 8, 1454–1460. doi: 10.1017/S1355838202021362
5. Chen, C., Ridzon, D. A., Broomer, A. J., Zhou, Z., Lee, D. H., Nguyen, J. T., et al. (2005). Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res. 33, e179. doi: 10.1093/nar/gni178
6. Choi, J. G., Bharaj, P., Abraham, S., Ma, H., Yi, G., Ye, C., et al. (2015). Multiplexing seven miRNA-Based shRNAs to suppress HIV replication. Mol. Ther. 23, 310–320. doi: 10.1038/mt.2014.205
7. Deng, Y., Wang, C. C., Choy, K. W., Du, Q., Chen, J., Wang, Q., et al. (2014). Therapeutic potentials of gene silencing by RNA interference: principles, challenges, and new strategies. Gene 538, 217–227. doi: 10.1016/j.gene.2013.12.019
8. Haasnoot, J., Westerhout, E. M., and Berkhout, B. (2007). RNA interference against viruses: strike and counterstrike. Nat. Biotechnol. 25, 1435–1443. doi: 10.1038/ nbt1369
9. Hutter, G., Nowak, D., Mossner, M., Ganepola, S., Mussig, A., Allers, K., et al. (2009). Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation. N. Engl. J. Med. 360, 692–698. doi: 10.1056/NEJMoa0802905
10. Kong, X., West, J. T., Zhang, H., Shea, D. M., M'Soka, T. J., and Wood, C. (2008). The human immunodeficiency virus type 1 envelope confers higher rates ofreplicative fitness to perinatally transmitted viruses than to nontransmitted viruses. J. Virol. 82, 11609–11618. doi: 10.1128/JVI.00952-08
11. Leonard, J. N., and Schaffer, D. V. (2005). Computational design of antiviral RNA interference strategies that resist human immunodeficiency virus escape. J. Virol. 79, 1645–1654. doi: 10.1128/JVI.79.3.1645-1654.2005
12. Liang, Z., Guo, Z., Wang, X., Kong, X., and Liu, C. (2012). Two retroviruses packaged in one cell line can combined inhibit the replication of HIV-1 in TZM-bl cells. Virol. Sin. 27, 339–344. doi: 10.1007/s12250-012-3263-8
13. Liu, Y. P., Haasnoot, J., and Berkhout, B. (2007). Design of extended short hairpin RNAs for HIV-1 inhibition. Nucleic Acids Res. 35, 5683–5693. doi: 10.1093/nar/gkm596
14. Liu, Y. P., von Eije, K. J., Schopman, N. C., Westerink, J. T., ter Brake, O., Haasnoot, J., et al. (2009). Combinatorial RNAi against HIV-1 using extended short hairpin RNAs. Mol. Ther. 17, 1712–1723. doi: 10.1038/mt.2009.176
15. Margolis, D. M., Garcia, J. V., Hazuda, D. J., and Haynes, B. F. (2016). Latency reversal and viral clearance to cure HIV-1. Science 353:aaf6517. doi: 10.1126/ science.aaf6517
16. McIntyre, G. J., Groneman, J. L., Yu, Y. H., Jaramillo, A., Shen, S., and Applegate, T. L. (2009). 96 shRNAs designed for maximal coverage of HIV-1 variants. Retrovirology 6:55. doi: 10.1186/1742-4690-6-55
17. Meister, G., and Tuschl, T. (2004). Mechanisms of gene silencing by double-stranded RNA. Nature 431, 343–349. doi: 10.1038/nature02873
18. Mollaie, H. R., Monavari, S. H., Arabzadeh, S. A., Shamsi-Shahrabadi, M., Fazlalipour, M., and Afshar, R. M. (2013). RNAi and miRNA in viral infections and cancers. Asian Pac. J. Cancer Prev. 14, 7045–7056. doi: 10.7314/APJCP. 2013.14.12.7045
19. Naito, Y., Nohtomi, K., Onogi, T., Uenishi, R., Ui-Tei, K., Saigo, K., et al. (2007). Optimal design and validation of antiviral siRNA for targeting HIV-1. Retrovirology 4:80. doi: 10.1186/1742-4690-4-80
20. Paddison, P. J., Caudy, A. A., Bernstein, E., Hannon, G. J., and Conklin, D. S. (2002). Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells. Genes Dev. 16, 948–958. doi: 10.1101/gad.981002
21. Passaes, C. P., and Saez-Cirion, A. (2014). HIV cure research: advances and prospects. Virology 45, 340–352. doi: 10.1016/j.virol.2014.02.021
22. Pennings, P. S. (2013). HIV drug resistance: problems and perspectives. Infect Dis. Rep. 5(Suppl. 1):e5. doi: 10.4081/idr.2013.s1.e5
23. Philippidis, A. (2013). Gene therapy briefs. Hum. Gene Ther. 24, 565–567. doi: 10.1089/hum.2013.250
24. Pusch, O., Boden, D., Silbermann, R., Lee, F., Tucker, L., and Ramratnam, B. (2003). Nucleotide sequence homology requirements of HIV-1-specific short hairpin RNA. Nucleic Acids Res. 31, 6444–6449. doi: 10.1093/nar/gkg876
25. Saayman, S., Arbuthnot, P., and Weinberg, M. S. (2010). Deriving four functional anti-HIV siRNAs from a single Pol III-generated transcript comprising two adjacent long hairpin RNA precursors. Nucleic Acids Res. 38, 6652–6663. doi: 10.1093/nar/gkq460
26. Senserrich, J., Pauls, E., Armand-Ugon, M., Clotet-Codina, I., Moncunill, G., Clotet, B., et al. (2008). HIV-1 resistance to the anti-HIV activity of a shRNA targeting a dual-coding region. Virology 372, 421–429. doi: 10.1016/j.virol.2007.10.045
27. Shah, P. S., Pham, N. P., and Schaffer, D. V. (2012). HIV develops indirect crossresistance to combinatorial RNAi targeting two distinct and spatially distant sites. Mol. Ther. 20, 840–848. doi: 10.1038/mt.2012.3
28. Spanevello, F., Calistri, A., Del Vecchio, C., Mantelli, B., Frasson, C., Basso, G., et al. (2016). Development of lentiviral vectors simultaneously expressing multiple siRNAs against CCR5, vif and tat/rev genes for an HIV-1 gene therapy approach. Mol. Ther. Nucleic Acids 5, e312. doi: 10.1038/mtna.2016.24
29. ter Brake, O., and Berkhout, B. (2005). A novel approach for inhibition of HIV-1 by RNA interference: counteracting viral escape with a second generation of siRNAs. J. RNAi Gene Silencing 1, 56–65.
30. von Eije, K. J., ter Brake, O., and Berkhout, B. (2008). Human immunodeficiency virus type 1 escape is restricted when conserved genome sequences are targeted by RNA interference. J. Virol. 82, 2895–2903. doi: 10.1128/JVI.02035-07
31. Westerhout, E. M., Ooms, M., Vink, M., Das, A. T., and Berkhout, B. (2005). HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genome. Nucleic Acids Res. 33, 796–804. doi: 10.1093/nar/gki220
32. Woods, E. A., and Foisy, M. M. (2014). Antiretroviral-related alopecia in HIVinfected patients: a review of the literature. Ann. Pharmacother. 48, 1187–1193. doi: 10.1177/1060028014540451